The Global Price Reporting Mechanism (GPRM) contains information on transaction prices and quantities of antiretrovirals (ARVs), tuberculosis drugs, malaria drugs and HIV, TB and Malaria diagnostics purchased by HIV/AIDS, TB and Malaria programmes in low-income countries, lower middle-income countries† and upper middle-income countries.
The country classification is done using the World Bank Atlas calculation and classification method and the focus group is low-income, lower middle-income and upper-middle-income countries.
The GPRM complements reports of price quotes from pharmaceutical companies as well as smaller sets of transaction prices published by other sources. Based on assessments done using the full data set in the GPRM for year 2008 and 2009, GPRM currently represents at least 75% of all public procurement of ARVs, 50% of all public procurement of TB medicines and 30% of anti malaria (ACTs) public procurement.
This summary report features the transaction data of ARVs in 2008, 2009 and the three first quarters of 2010, and is based on information received by 10 November 2010 from the partners...